In a regulatory filing, Beauty Health disclosed that its CEO Andrew Stanleick bought 16.5K shares of common stock on August 17th in a total transaction size of $99.8K.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SKIN:
- Beauty Health price target lowered to $16.50 from $35 at DA Davidson
- Beauty Health price target lowered to $9 from $15 at TD Cowen
- The Beauty Health (NASDAQ:SKIN) Glows On Healthy Q2 Numbers
- Beauty Health backs FY23 revenue view $460M-$480M, consensus $461.57M
- Beauty Health reports Q2 EPS 3c, consensus 5c